Pharma Major Lupin announced that it has received final approval for its Fluocinonide Topical Solution USP, 0.05% from the United States Food and Drug Administration (FDA) to market a generic version of County Line Pharmaceuticals, LLC's Fluocinonide Topical Solution USP, 0.05%.

Lupin's Fluocinonide Topical Solution USP, 0.05% is AT rated generic equivalent of County Line Pharmaceuticals, LLC's Fluocinonide Topical Solution USP, 0.05%. It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Shares of the company declined Rs 3.3, or 0.29%, to trade at Rs 1,139.55. The total volume of shares traded was 106,322 at the BSE (3.20 p.m., Monday).